Sorivudine

From Wikipedia, the free encyclopedia

Sorivudine
Systematic (IUPAC) name
5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Identifiers
CAS number 77181-69-2
ATC code J05AB15
PubChem 5282192
Chemical data
Formula C11H13BrN2O6 
Mol. mass 349.14 g/mol
Synonyms BV-araU,Bromovinyl araU,5-Bromovinyl-araU
Pharmacokinetic data
Bioavailability  ?
Metabolism Viral thymidine kinase
Half life  ?
Excretion kidney
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes oral

Sorivudine (INN) chemical name (E)-5-(2-Bromovinyl)- 1β-D-arabinofuranosyluracil, is a thymine analogue antiviral drug, marketed under trade names such as Usevir (Nippon Shoji,Eisai) and Brovavir (BMS).

Contents

[edit] Pharmacology

[edit] Feature

  • First-line treatment of herpes drug acyclovir was (Zovirax, Activir) from VZV strong activity of the virus.
  • Superior gastrointestinal absorption, absorption from the gastrointestinal tract after the most degrading without being excreted as urine.

[edit] Mechanism of action

  • Sorivudine is phosphorylated by thymidine kinase activity in the body and is absorbed into the virus's DNA, to inhibit viral DNA replication of DNA polymerase to make it fail to inhibit viral growth.

[edit] Microbiology

Sorivudine is active against most species in the herpesvirus family.

Languages